Cargando…
New definitions of susceptibility categories EUCAST 2019: clinic application
In January 2019, the European Committee for the Study of Antimicrobial Susceptibility (EUCAST) introduced some changes in the definitions of clinical categories for antibiotic susceptibility. The objective of these changes was to improve the credibility of category “I”, optimizing and lengthening th...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Quimioterapia
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717465/ https://www.ncbi.nlm.nih.gov/pubmed/36285865 http://dx.doi.org/10.37201/req/s03.18.2022 |
_version_ | 1784842907856928768 |
---|---|
author | Díaz, Sandra G. Nabal Robles, Olga Algara Moya, Juan M. García-Lechuz |
author_facet | Díaz, Sandra G. Nabal Robles, Olga Algara Moya, Juan M. García-Lechuz |
author_sort | Díaz, Sandra G. Nabal |
collection | PubMed |
description | In January 2019, the European Committee for the Study of Antimicrobial Susceptibility (EUCAST) introduced some changes in the definitions of clinical categories for antibiotic susceptibility. The objective of these changes was to improve the credibility of category “I”, optimizing and lengthening the survival and use of available antibiotics in the face of increasing antimicrobial resistance. This article aims to describe and explain these changes in the EUCAST criteria as well as make a short review about the factors on which the antibiotic susceptibility criteria depend. |
format | Online Article Text |
id | pubmed-9717465 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Sociedad Española de Quimioterapia |
record_format | MEDLINE/PubMed |
spelling | pubmed-97174652022-12-08 New definitions of susceptibility categories EUCAST 2019: clinic application Díaz, Sandra G. Nabal Robles, Olga Algara Moya, Juan M. García-Lechuz Rev Esp Quimioter Current Strategies for Infectious Diseases Management In January 2019, the European Committee for the Study of Antimicrobial Susceptibility (EUCAST) introduced some changes in the definitions of clinical categories for antibiotic susceptibility. The objective of these changes was to improve the credibility of category “I”, optimizing and lengthening the survival and use of available antibiotics in the face of increasing antimicrobial resistance. This article aims to describe and explain these changes in the EUCAST criteria as well as make a short review about the factors on which the antibiotic susceptibility criteria depend. Sociedad Española de Quimioterapia 2022-10-24 2022 /pmc/articles/PMC9717465/ /pubmed/36285865 http://dx.doi.org/10.37201/req/s03.18.2022 Text en © The Author 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/). |
spellingShingle | Current Strategies for Infectious Diseases Management Díaz, Sandra G. Nabal Robles, Olga Algara Moya, Juan M. García-Lechuz New definitions of susceptibility categories EUCAST 2019: clinic application |
title | New definitions of susceptibility categories EUCAST 2019: clinic application |
title_full | New definitions of susceptibility categories EUCAST 2019: clinic application |
title_fullStr | New definitions of susceptibility categories EUCAST 2019: clinic application |
title_full_unstemmed | New definitions of susceptibility categories EUCAST 2019: clinic application |
title_short | New definitions of susceptibility categories EUCAST 2019: clinic application |
title_sort | new definitions of susceptibility categories eucast 2019: clinic application |
topic | Current Strategies for Infectious Diseases Management |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717465/ https://www.ncbi.nlm.nih.gov/pubmed/36285865 http://dx.doi.org/10.37201/req/s03.18.2022 |
work_keys_str_mv | AT diazsandragnabal newdefinitionsofsusceptibilitycategorieseucast2019clinicapplication AT roblesolgaalgara newdefinitionsofsusceptibilitycategorieseucast2019clinicapplication AT moyajuanmgarcialechuz newdefinitionsofsusceptibilitycategorieseucast2019clinicapplication |